During 2019 PREZEDX are constructing phase 1 of a facility that has an annual production target of 10 tonnes.
Phase 2 will see PREZEDX's production increase to 50 tonnes per annum.
Oncompletion of phase 3 in 2021 PREZEDX's output will increase to 100 tonnes per annum.
"Our facility will service the growing demand of the European market, initially focusing on the supply of pharmaceutical grade cannabis to German,British and Portuguese patients."
Our aim is to provide high-quality, low-cost medical cannabis products in Portugal and across emerging cannabis markets in Europe. Our team of experienced pharmaceutical, horticultural and biotechnology personnel will supply safe, reliable, GMP-certified cannabis to pharmacies across the continent, ensuring patients have access to the medicine they need.